Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories medical Devices — Annual Foreign Exchange Impact (%) (%)
Form 10-K MD&A ('Components of % Change' table)
Latest, FY2025
0.7%
Period ended Dec 31, 2025
Change on a year earlier
+2.0 pts
-1.3% in FY2024
History
8 years
Since FY2018
Sources
7
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Medical Devices — Annual Foreign Exchange Impact (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0.7% | +2.0 pts | SEC Filing (0001628280-26-010185) ↗ |
| FY2024 | Dec 31, 2024 | -1.3% | -0.3 pts | SEC Filing (0001628280-26-010185) ↗ |
| FY2023 | Dec 31, 2023 | -1.0% | +4.9 pts | SEC Filing (0001628280-25-007110) ↗ |
| FY2022 | Dec 31, 2022 | -5.9% | -8.4 pts | SEC Filing (0001628280-24-005348) ↗ |
| FY2021 | Dec 31, 2021 | 2.5% | +2.4 pts | SEC Filing (0001628280-23-004026) ↗ |
| FY2020 | Dec 31, 2020 | 0.1% | +3.0 pts | SEC Filing (0001104659-22-025141) ↗ |
| FY2019 | Dec 31, 2019 | -2.9% | -4.0 pts | SEC Filing (0001104659-21-025751) ↗ |
| FY2018 | Dec 31, 2018 | 1.1% | – | SEC Filing (0001104659-20-023904) ↗ |
Cite this data
StockData. (2026). Abbott Laboratories Medical Devices — Annual Foreign Exchange Impact (%) (%), annual FY2018–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/md-fx-comp-yoy
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.